Highlights Eurofins Scientific SE

Equities

Market Closed - Euronext Paris Other stock markets 11:35:14 2024-04-29 am EDT			5-day change	1st Jan Change
58.7 ^EUR	+3.64%		-2.62%	-0.47%

Apr. 29	CAC40: France's rating maintained = non-event	CF
Apr. 29	CAC40: starts the week slightly up, crosses the 8100 mark	CF

CAC40: starts the week slightly up, crosses the 8100 mark	Apr. 29	CF
CAC40: interest rates soar, pulling back below 8100 pts	Apr. 24	CF
EUROFINS SCIENTIFIC : Q1 sees a lacklustre start to the year; 2024 outlook confirmed	Apr. 24
CAC40: rise to 8.150, but interest-rate tensions hinder progress	Apr. 24	CF
CAC40: pullback reduced, WStreet +0.7%, Brent at $91, Gold at $233	Apr. 05	CF
CAC40: easily preserves 8,000Pts, NFP has no impact	Apr. 05	CF
CAC40: ends the day balanced after a salvo of statistics	Apr. 04	CF
CAC40: frozen at 8,155, W-Street well disposed, gold at its zenith	Apr. 04	CF
EUROFINS SCIENTIFIC : Berenberg raises its price target	Apr. 04	CF
CAC40: up slightly after PMI figures	Apr. 04	CF
Eurofins Scientific to Purchase US-based Ascend Clinical	Apr. 03	MT
Eurofins completes acquisition of Ascend Clinical	Apr. 03	CF
Eurofins Scientific SE acquired Ascend Clinical, LLC.	Apr. 02	CI
CAC40: ends with a balanced performance, helped by the banking sector	Mar. 28	CF
CAC40: all-time high, tackles 8250 resistance level	Mar. 28	CF
Enzymatica Obtains CE Marking for ColdZyme Mouth Spray	Mar. 11	MT
EUROFINS SCIENTIFIC : Lackluster FCF and dividend cut weigh on the share price	Feb. 28
Eurofins: Adjusted EBITDA down 10% by 2023	Feb. 27	CF
Eurofins Scientific SE Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 27	CI
NeoSpectra and Eurofins QTA Collaborate to Advance On-Site Analysis Solutions for the Food Industry	Jan. 15	CI

No results for this search

EUROFINS SCIENTIFIC : Q1 sees a lacklustre start to the year; 2024 outlook confirmed

April 24, 2024 at 11:50 am EDT